Scripintelligence - AstraZeneca/Targacept: Another nail in the coffin for TC-5214

Scrip Clinica Scrip Regulatory Affairs Scrip Clinical Research AnimalPharm

Advanced Search

Research & Development

AstraZeneca/Targacept: Another nail in the coffin for TC-5214
22 December 2011
Daniel Chancellor

dchancellor@datamonitor.com

Please Login to read the full article.

Not a subscriber? Subscribe to Scrip Request a FREE Trial

RELATED CONTENT

NEWS Scrip News

AstraZeneca to take $381.5 million charge after two major trial failures
Major disappointment for Targacept and AstraZeneca in Phase III depression trial
Lundbeck CEO outlines commercial strategy for alcohol-dependency and depression candidates
Positive top-line data for Forest/Richter's antipsychotic cariprazine as filing nears

Other Informa News

COMMENT Scrip Comment

Back to MAbs for Pfizer as Dimebon reaches the end of the road in Alzheimer's

Other Informa Comment

DePuy is still in a good place despite recall woes

FEATURES Other Informa Features

EVENTS

Understanding the basics of EU regulatory affairs

Today

The Rembrandt Hotel, London

Clinical trial regulatory and guideline requirements

07 June 2012

The Rembrandt Hotel, London

16th Annual European PRO & ePRO Congress

12 June 2012

Annecy, France

JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36

Home

Therapy Sector

Generics

Business

Policy & Regulation

Research & Development

International

Terms & Conditions

Scrip Regulatory Affairs

Scrip Clinical Research

Animal Pharm